InMode/$INMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About InMode
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Ticker
$INMD
Sector
Primary listing
Industry
Health Care Equipment and Supplies
Headquarters
Yokne'am, Israel
Employees
599
ISIN
IL0011595993
Website
InMode Metrics
BasicAdvanced
$891M
6.15
$2.29
1.96
-
Price and volume
Market cap
$891M
Beta
1.96
52-week high
$19.78
52-week low
$13.14
Average daily volume
1.6M
Financial strength
Current ratio
8.735
Quick ratio
7.505
Long term debt to equity
0.902
Total debt to equity
0.902
Profitability
EBITDA (TTM)
110.794
Gross margin (TTM)
80.03%
Net profit margin (TTM)
44.80%
Operating margin (TTM)
28.05%
Effective tax rate (TTM)
-25.67%
Revenue per employee (TTM)
$660,000
Management effectiveness
Return on assets (TTM)
8.62%
Return on equity (TTM)
24.50%
Valuation
Price to earnings (TTM)
6.149
Price to revenue (TTM)
2.708
Price to book
1.57
Price to tangible book (TTM)
1.57
Price to free cash flow (TTM)
8.714
Free cash flow yield (TTM)
11.48%
Free cash flow per share (TTM)
161.81%
Growth
Revenue change (TTM)
-15.84%
Earnings per share change (TTM)
8.69%
3-year revenue growth (CAGR)
1.26%
3-year earnings per share growth (CAGR)
5.22%
What the Analysts think about InMode
Analyst ratings (Buy, Hold, Sell) for InMode stock.
Bulls say / Bears say
InMode's substantial cash reserves of approximately $800 million, representing 55% of its market capitalization, provide a strong financial foundation for potential strategic investments or shareholder returns. (stocktitan.net)
The company's high gross margins of around 80% and healthy free cash flow indicate efficient operations and profitability. (stocktitan.net)
InMode's recent Health Canada certification of the IgniteRF Platform with QuantumRF Technology opens new market opportunities in Canada, potentially driving revenue growth. (finance.yahoo.com)
InMode reported a 3% year-over-year revenue decline in Q1 2025, with revenue falling to $77.9 million from $80.3 million, indicating potential challenges in maintaining growth. (stocktitan.net)
The company lowered its full-year 2025 revenue guidance to between $395 million and $405 million, down from previous estimates, reflecting concerns over future performance. (stocktitan.net)
Barclays reduced its price target for InMode from $27.00 to $26.00, suggesting tempered expectations for the stock's performance. (etfdailynews.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
InMode Financial Performance
Revenues and expenses
InMode Earnings Performance
Company profitability
InMode News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for InMode stock?
InMode (INMD) has a market cap of $891M as of July 18, 2025.
What is the P/E ratio for InMode stock?
The price to earnings (P/E) ratio for InMode (INMD) stock is 6.15 as of July 18, 2025.
Does InMode stock pay dividends?
No, InMode (INMD) stock does not pay dividends to its shareholders as of July 18, 2025.
When is the next InMode dividend payment date?
InMode (INMD) stock does not pay dividends to its shareholders.
What is the beta indicator for InMode?
InMode (INMD) has a beta rating of 1.96. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.